Clinical Trial Update: Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial update assesses the safety of GM-CT-01 with and without 5-fluorouracil in patients with solid tumors, including colorectal cancer, lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Prostate Cancer

Drugs mentioned

• GM-CT-01 (GM-CT-01)

Snippet

Sponsor: Galectin Therapeutics Inc. | Conditions: Colorectal Cancer, Lung Cancer | Phase 1 | Status: COMPLETED